Yixiang Zhu

10PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 20, 2022
Correlations of switch/sucrose nonfermentable complex mutations with clinical outcomes in advanced non-small cell lung cancer.

Geyun Chang, Weihua Li, Hua Bai

|Jul 02, 2022
Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA.

Yan Li, Ziyi Xu, Shouzheng Wang

|Mar 29, 2022
Establishment of prognostic nomograms for predicting the progression free survival of EGFR-sensitizing mutation, advanced lung cancer patients treated with EGFR-TKIs.

Xinyang Du, Hua Bai, Zhijie Wang

|Dec 23, 2021
Front-Line Therapy in EGFR Exon 19 Deletion and 21 Leu858Arg Mutations in Advanced Non-Small Cell Lung Cancer: A Network Meta-Analysis.

Tongji Xie, Zihua Zou, Chengcheng Liu

|Aug 12, 2020
Comparative study of clinicopathological characteristics and prognosis between combined and pure small cell lung cancer (SCLC) after surgical resection.

Yiying Guo, Lin Yang, Li Liu

|Jun 01, 2019
What are the clinical symptoms and physical signs for non-small cell lung cancer before diagnosis is made? A nation-wide multicenter 10-year retrospective study in China.

Pu-Yuan Xing, Yi-Xiang Zhu, Le Wang

Pageof 2

Frequent Collaborators

3 joint publications

Yuxin Mu

3 joint publications

Junling Li

2 joint publications

Jie Wang

2 joint publications

Jianchun Duan